Lawsuits Allege Fresenius Failed to Warn of GranuFlo Dialysis Dangers

Lawsuits Allege Fresenius Failed to Warn of GranuFlo Dialysis Dangers

By Anne Bucher

Each year, approximately 400,000 Americans receive dialysis treatment to treat kidney failure. Nearly a third of these patients are administered GranuFlo or NaturaLyte, two dialysis products that are manufactured by Fresenius. In 2010, these Fresenius products surpassed $12 billion in sales. However, many people have suffered serious side effects after being administered these drugs during their dialysis treatment. They are stepping forward and filing drug injury lawsuits against Fresenius, claiming that the company knew of their products’ risks but failed to warn doctors and patients about the potentially deadly risks associated with GranuFlo and NaturaLyte dosage errors.

Some of the potential side effects of GranuFlo and NaturaLyte include:

• Cardiac arrest
• Metabolic alkalosis
• Low blood pressure
• Heart attack
• Stroke
• Arrhythmia
• Heart problems
• Death

Fresenius Failed to Warn About GranuFlo Dosage Errors

Ronnie Glasper recently filed a GranuFlo lawsuit against Fresenius, alleging that he was harmed by dosing errors during his dialysis treatment. According to court documents, Glasper was administered GranuFlo or NaturaLyte during his dialysis treatment at a Fresenius health care center. He suffered from a stroke and heart attack shortly after treatment. Like many GranuFlo lawsuit plaintiffs, Glasper claims Fresenius was well aware of the potential for health care professionals to make fatal dosing errors, but the company failed to warn doctors of this risk.

On November 4, 2011, Fresenius circulated an internal memo that warned about the potentially fatal health risks associated with GranuFlo and NaturaLyte dosing errors. The memos warn that the concentrates of these drugs can lead to patients developing metabolic alkalosis, a condition that can lead to arrhythmia or cardiac arrest. However, the company did not inform other physicians outside their own clinics or the U.S. Food & Drug Administration (FDA) about these risks. While Glasper was treated as a Fresenius facility, his doctor had not been made aware of the dosage risks.

Due to the serious dangers posed by GranuFlo and NaturaLyte, the FDA issued a Class I recall of the products. Class I recalls are reserved for seriously dangerous or defective products that are likely to lead to significant health problems or death.

File a GranuFlo Lawsuit

If you or someone you love has suffered from serious injuries following kidney dialysis treatment, contact a lawyer immediately. You may have been administered the recalled drugs and may be able to receive compensation for your pain and suffering, medical expenses, lost wages and other injuries. Visit the Kidney Dialysis Heart Attack, GranuFlo & NaturaLyte Recall Class Action Lawsuit Settlement Investigation to learn more about your legal rights and how to contact a GranuFlo attorney.

If you submit information about your GranuFlo or NaturaLyte injury, a lawyer will conduct a free case evaluation to determine if you qualify to file a GranuFlo lawsuit. Filing a drug injury lawsuit against Fresenius will help to hold the company accountable for selling an unreasonably dangerous product to patients and medical professionals. If a loved one died after receiving GranuFlo or NaturaLyte during dialysis, you may be able to file a wrongful death lawsuit to recover funeral expenses, medical expenses and other compensation for your loss.